Introduction
============

Glaucoma, one of the three major eye diseases that lead to blindness, is caused by the depression and atrophy of optic papilla ([@b1-etm-0-0-7584]). In recent years, it has been found that approximately 60 million individuals suffer from open angle or angle-closure glaucoma worldwide, and glaucoma is second only to cataract in causing blindness to patients ([@b2-etm-0-0-7584]). Primary open angle glaucoma (POAG) is one of the most common glaucoma types with the clinical manifestations of pathological intraocular pressure (IOP) elevation which causes optic nerve blood supply insufficiency in patients ([@b3-etm-0-0-7584]). Previous findings showed that elevated IOP is closely related to increased aqueous outflow resistance in trabecular meshwork, and the main function of trabecular meshwork is to control the aqueous flow direction ([@b4-etm-0-0-7584]). Another study has shown that the abnormal deposition of extracellular matrix (ECM) is the main factor causing increased aqueous outflow resistance in trabecular meshwork and elevated IOP ([@b5-etm-0-0-7584]).

Being a hot research field in recent years, microRNA (miR) is a kind of non-coding short-chain RNA with a length of approximately 22 nucleotides that functions mainly to inhibit the translation and transcription of a target gene by binding to the 3′ untranslated region (UTR) of its cognate mRNA, thereby changing the expression of the gene ([@b6-etm-0-0-7584]). Increasing number of studies have shown that miR is closely related to tumor and cardiovascular diseases ([@b7-etm-0-0-7584],[@b8-etm-0-0-7584]). Moreover, there are related studies showing that miR is related to glaucoma. The study of Zhang *et al* ([@b9-etm-0-0-7584]) has shown that reduced miR-187 expression in retinal cells promotes Smad7 expression and induces retinal ganglion cells (RGCs) apoptosis in patients with glaucoma. Current research shows that, miR-144-3p is one of the important members of the miR family ([@b10-etm-0-0-7584],[@b11-etm-0-0-7584]). It is differentially expressed in a variety of tumors and cardiovascular diseases, and is closely related to the progression of these diseases. Fibronectin-1 (FN-1), also known as FN, is a high-molecular-weight glycoprotein that can regulate various biological functions and widely exists in animal tissues and tissue fluids ([@b12-etm-0-0-7584]). A study has shown that, the expression of FN-1 protein is increased in ECM of human trabecular meshwork cells (HTMCs) in POAG patients, and FN can promote ECM deposition to block trabecular meshwork, thereby causing an increase in pathological IOP ([@b13-etm-0-0-7584]). However, according to Liang *et al* ([@b14-etm-0-0-7584]), the luciferase reporter gene confirms that miR-144-3p can targetly regulate FN-1 expression. However, it is not clear whether miR-144-3p is differentially expressed in glaucoma patients, or it can regulate the function of HTMCs and the role of FN-1.

Therefore, this study explored the regulatory effects of miR-144-3p on HTMC proliferation, invasion and FN-1, thus providing a reference for clinicians.

Materials and methods
=====================

### Cell source

HTMCs (BNCC342361; BeNa Culture Collection Company, Beijing, China).

### Main kits and instruments

TRIzol Extraction kit, RIPA, BCA Protein kit, Lipofectamine™ 2000, ECL Luminescence kit, Transwell kit (nos. 15596018, 89900, 23225, 11668030, 35055, A1142801; Thermo Fisher Scientific, Inc., Shanghai, China); H~2~O~2~, FBS, DMEM, Penicillin-streptomycin double-antibody (216763, F2442, D5796, V900929; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany); RT-qPCR kit, TransScript Green miRNA Two-Step RT-qPCR SuperMix (AQ202-01; Beijing TransGen Biotech Co., Ltd., Beijing, China), FN-1 monoclonal antibody, β-actin monoclonal antibody, horseradish peroxidase (HRP)-labeled goat anti-mouse IgG secondary antibody (nos. MAB19182, MAB8929, HAF007; R&D Systems, Inc., Minneapolis, MN, USA), CCK-8 kit (C0037; Beyotime Institute of Biotechnology, Shanghai, China), miR-144-3p primer sequence, inhibition and over-expression sequences, and independence sequence were designed and produced by Sangon Biotech Co., Ltd. (Shanghai, China).

### Cell culture

The HTMCs were placed in DMEM medium (10% FBS, penicillin-streptomycin double-antibody) and transferred to an incubator containing 5% CO~2~ at 37°C. The solution was changed every 2 days and 0.25% trypsin was used for digestion and passage when the cell fusion reached approximately 90%.

### Modeling and grouping

The 3rd-4th generation cells were collected and the density was adjusted to 4×10^6^, then inoculated in a 6-well plate. Oxidative stress models were established 24 h later, and the cells were cultured in a 37°C constant temperature incubator with 300 µM H~2~O~2~ serum-free DMEM medium for 2 h. There were 5 groups in this experiment: the control, the blank, the independence sequence, the over-expression and the inhibition groups. The cells in the control group were not cultured with H~2~O~2~, while the blank, the independence sequence, the over-expression and the inhibition groups all used H~2~O~2~ for induction culture. Additionally, the cells in the independence sequence, the over-expression and the inhibition groups were transferred to corresponding sequence plasmids respectively using Lipofectamine™ 2000. The procedure was carried out according to the protocol and the cells were cultured in an incubator for 2 h.

### Clinical data of patients

A total of 40 POAG patients treated in Xuzhou No. 1 People\'s Hospital (Xuzhou, China) were included into the observation group, including 25 males and 15 females with an average age of 45.24±8.23 years, and they all underwent systematic ophthalmological examinations, including optometry, best corrected visual acuity (BCVA), slit lamp, fundus examination, IOP measurement, gonioscopy, visual field and visual evoked potential (VEP) tests. Another 40 healthy people with normal visual acuity, heart, lung, liver and kidney laboratory tests were collected as a normal group, including 22 males and 18 females with an average age of 46.22±7.69 years. There was no difference in sex and age between the two groups (P\>0.05). Inclusion criteria were: i) patients with complete clinical data; ii) patients with no family history of glaucoma; and iii) patients conforming to Diagnosis and Treatment of Primary Glaucoma Consensus in China. Exclusion criteria were: i) patients complicated with malignant tumor; ii) patients with cardio-cerebrovascular disease; iii) patients receiving glaucoma treatment before this test; and iv) patients with no previous operation history caused atrial morphological changes and liver fibrosis.

The study was approved by the Ethics Committee of Xuzhou Medical University (Xuzhou, China). Patients who participated in this study had complete clinical data. Signed informed consents were obtained from the patients or the guardians.

### Sample collection

Fasting venous blood samples (5 ml) of patients in the two groups were collected in the morning, left to stand for 30 min, and centrifuged at 1,509.3 × g for 10 min at 25°C. The serum was collected for follow-up experiments.

### RT-qPCR detection

Total RNAs were extracted from the patient serum and the cells of each group after 2 h of transfection and culture using the TRIzol extraction reagent. The purity, concentration and integrity of total RNAs were detected using an ultraviolet spectrophotometer and 1% agarose gel electrophoresis. The total RNA was reverse transcribed into cDNA using 2X TS miRNA Reaction Mix in TransScript Green miRNA Two-Step RT-qPCR SuperMix, and the specific operation steps were carried out according to the manufacturer\'s protocol. Then PCR amplification experiment was carried out for the PCR reaction system: 1 µl of cDNA, 0.4 µl of each upstream and downstream primers ([Table I](#tI-etm-0-0-7584){ref-type="table"}), 10 µl of 2X TransTaq^®^ Tip Green qPCR SuperMix, 0.4 µl of Passive Reference Dye (50X), made up to 20 µl with ddH~2~O. PCR reaction conditions were: pre-denaturation at 94°C for 30 sec, denaturation at 94°C for 5 sec, annealing at 60°C for 15 sec, extension at 72°C for 10 sec, for a total of 40 cycles. Each sample was tested in 3 repeat wells, and the experiment was carried out 3 times. In this study, U6 was used as an internal reference and 2^−ΔΔCq^ was used to analyze the data ([@b15-etm-0-0-7584]). β-actin was used as the internal reference in this study.

### Western blot (WB) detection

Total protein was extracted from the collected cells using the RIPA lysis method, and its concentration was detected with the bicinchoninic acid (BCA) method and adjusted to 4 µg/µl. The proteins were separated by 12% SDS-PAGE and then transferred to a polyvinylidene difluoride membrane. The membrane was stained with Ponceau S working solution, immersed in PBS for 5 min and then washed, blocked with 5% skimmed milk powder for 2 h, and finally incubated overnight at 4°C with the primary antibodies (1:1,000). Following washing to remove primary antibodies (FN-1 and β-actin monoclonal antibody), the HRP-labeled goat anti-mouse secondary antibody (1:5,000) was added to the membrane for a 1 h incubation at 37°C. After that, the membrane was rinsed 3 times with PBS, for 5 min each time. The protein bands on the membrane were developed in the dark using the enhanced chemiluminescence (ECL) reagent, and the excess liquid on the membrane was absorbed with a filter paper. The luminescent protein bands were scanned and the gray value was analyzed using Quantity One software. The relative expression level of each protein was: the gray value of the target protein band/the gray value of the β-actin protein band.

### Cell proliferation detection

The 3rd-4th generation cells were collected and the density was adjusted to 4×10^6^, then inoculated in a 6-well plate. Oxidative stress models were established after 24 h and the cells were transfected, then cultured for 48 h and 10 µl of CCK solution and 90 µl basal medium (DMEM) were added to each well, and cultured at 37°C for 2 h. The optical density (OD) value of cells in each group was tested at 570 nm absorbance using a microplate reader.

### Cell invasion detection

Transwell chamber was placed in a 24-well plate, 500 µl DMEM culture solution was added to the upper chamber, and 100 µl DMEM was added to the lower chamber, then the cells were cultured for 1 h (37°C). The 3rd-4th generation cells were collected and the density was adjusted to 4×10^6^, then inoculated in a 6-well plate. Oxidative stress models were established after 24 h and the cells were transfected, digested and resuspended with 0.25% trypsin, then added into a serum-free DMEM medium. The cells then were inoculated in a 24-well plate, and the density was adjusted by 1.5×10^6^ cells. The Transwell chamber was taken out, the lower chamber was replaced with 100% FBS, and 100 µl cell suspension was added into the upper one, then the cells were incubated at 37°C for 10 h. The substrates and cells that did not penetrate the membrane surface in the upper chamber were wiped off, washed three times with PBS, fixed with paraformaldehyde for 10 min, flushed three times with double-distilled water, dyed with 0.1% crystal violet for 10 min after drying, then rinsed three times with double-distilled water. A microscope was used to observe the cell invasion.

### Statistical analysis

In this study, SPSS20.0 (Cabit Information Technology Co., Ltd., Shanghai, China) software package was used to carry out statistical analysis on the collected data. GraphPad Prism 7 (Soft Head Technology Co., Ltd., Shenzhen, China) was used to draw the data figure. The measurement data were expressed as mean ± standard deviation. The comparison between the two groups was carried out by independent sample t-test, and denoted by t. The comparison between multiple groups was carried out by variance analysis, and denoted by F, and the the pairwise comparison was carried out by LSD-t-test afterwards. P\<0.05 was considered to indicate a statistically significant difference between the two groups.

Results
=======

### Expression of miR-144-3P in serum of patients

By detecting the expression of miR-144-3p in serum of the patients, it was found that the expression in the normal group was significantly higher than that in the observation group, with significant differences (P\<0.001; [Fig. 1](#f1-etm-0-0-7584){ref-type="fig"}).

### Expression of miR-144-3p in transfected cells

The detection of miR-144-p expression in cells of each group after transfection showed that there was a significant difference in the expression of miR-144-3p among groups (F=100.954, P\<0.001). The expression in the control group was significantly higher than that in the blank, the independence sequence and the inhibition groups, but significantly lower than that in the over-expression group (P\<0.05). While the expression in blank and independence sequence groups was significantly higher than that in the inhibition group but lower than that in control and the over-expression groups (P\<0.05). There was no significant difference between the blank and the independence sequence groups (P\>0.05). However, the expression of miR-144-p in the inhibitory group was significantly lower than that in the other four groups (P\<0.05), and the expression in the over-expression group was significantly higher than that in other four groups (P\<0.05; [Table II](#tII-etm-0-0-7584){ref-type="table"}).

### Cell proliferation in each group after 48 h

The comparison of OD value among the five groups of cells cultured for 48 h showed that there was a significant difference in cell proliferation among groups (F=29.146, P\<0.001). The value in the over-expression group was significantly higher than that in the other groups (P\<0.05), and in the inhibition group was significantly lower than that in the other groups (P\<0.05). There was no difference between the blank and the independence sequence groups (P\>0.05), while the OD value in these two groups was significantly higher than that in the inhibition group but lower than that in the control and the over-expression groups (P\<0.05; [Table III](#tIII-etm-0-0-7584){ref-type="table"} and [Fig. 2](#f2-etm-0-0-7584){ref-type="fig"}).

### Cell invasion

The number of cell-penetration in each group was counted and found that there was a significant difference in the number of cell-penetration among groups (F=52.656, P\<0.001). The number in the over-expression group was significantly higher than that in other groups (P\<0.05), and that in the inhibition group had the least compared with the other four groups (P\<0.05). There was no significant difference in the number of cell-penetration between the blank and the independence sequence groups (P\>0.05), and the number in these two groups significantly decreased compared with the control and the over-expression groups, but significantly increased compared with the inhibition group (P\<0.05; [Table IV](#tIV-etm-0-0-7584){ref-type="table"} and [Fig. 3](#f3-etm-0-0-7584){ref-type="fig"}).

### Expression of FN-1 protein

The expression of FN-1 protein in cells of each group was detected, and the results of Western blotting showed that there was a significant difference in the expression of FN-1 among groups (F=25.611, P\<0.001). The expression in the over-expression group was significantly lower than that in the other four groups (P\<0.05). The expression in the blank and the independence sequence groups had no significant difference (P\>0.05), but was significantly higher than that in the control and the over-expression groups and significantly lower than that in the inhibition group (P\<0.05). The expression of FN-1 protein in the inhibition group was significantly higher than that in the other four groups (P\<0.05; [Table V](#tV-etm-0-0-7584){ref-type="table"} and [Fig. 4](#f4-etm-0-0-7584){ref-type="fig"}).

Discussion
==========

Glaucoma is a serious and irreversible blinding eye disease, of which POAG is the most common type. However, each type can cause retinal ganglion cell damage ([@b16-etm-0-0-7584]). The clinical pathological manifestations of glaucoma are mainly elevated IOP caused by excessive aqueous humor. Therefore, the main way to treat glaucoma is to reduce aqueous humor secretion or aqueous outflow resistance ([@b5-etm-0-0-7584]). Trabecular meshwork, an important part of aqueous humor circulation, mainly regulates ECM and aqueous outflow ([@b17-etm-0-0-7584]).

As a hot research field in recent years, miR has been shown to be closely related to diseases such as glaucoma ([@b18-etm-0-0-7584],[@b19-etm-0-0-7584]). Being an important member of the miR family, miR-144-3p plays a role in the miR-451 gene cluster and can also regulate the expression of a plurality of genes involved in erythropoiesis ([@b20-etm-0-0-7584]). It was shown that miR-144 is a potential therapeutic tool for treating ischemic heart disease ([@b21-etm-0-0-7584]). By contrast, Liu *et al* ([@b22-etm-0-0-7584]) showed that miR-144 was under-expressed in liver fibrosis cells. It is well known that fibrosis is an over-reaction in wound healing, which leads to excessive ECM that can be reduced by miR-144 regulating TGF-β1 expression. ECM deposition also occurs after HTMCs are damaged in glaucoma. However, whether miR-144-3p has the same expression in glaucoma patients has not yet been studied. Therefore, this study provided reference for treatment by exploring the effect of miR-144-3p on HTMCs and its expression in the serum of glaucoma patients.

Research has shown that there is a close relationship between chronic oxidative stress and the occurrence and development of trabecular meshwork lesions ([@b23-etm-0-0-7584]). Elevated IOP decreased blood flow velocity in glaucoma patients, resulting in the decrease of oxygen flow rate, thus keeping HTMCs in a hypoxic state. Therefore, in this study, HTMC oxidative stress models were established and the expression of miR-144-3p in HTMCs was detected. The results showed that the expression of miR-144-3p in the modeled cells was significantly lower than that in the control group without modeling, and the clinical detection showed that the expression in serum of normal people was significantly higher than that of glaucoma patients, indicating that miR-144-3p is expected to become a potential diagnostic indicator for glaucoma. FN-1, as a non-collagen a2 glycoprotein, participates in cell-to-cell and cell-to-matrix adhesion in the body ([@b24-etm-0-0-7584]). Babizhayev and Brodskaya ([@b25-etm-0-0-7584]) showed that there was a large amount of FN-1 deposition in the trabecular meshwork adjacent area and the Schlemm inner wall of HTMCs in POAG patients, and the deposition increased with the aggravation of the disease. By detecting the expression of FN-1 mRNA and protein in the cells after modeling, it was found that the expression in the blank group was significantly higher than that in the control group, which was basically similar to the expression of FN-1 in the HTMCs induced by glucocorticoid dexamethasone as indicated by Filla *et al* ([@b26-etm-0-0-7584]). However, it is not clear whether there is a connection between miR-144-3p and FN-1 protein. Therefore, Targetscan, an online miR target gene prediction software, was used in that study, and it was found that there were possible binding targets between miR-144-3p and FN-1 ([@b26-etm-0-0-7584]). Moreover, Liang *et al* ([@b14-etm-0-0-7584]) confirmed their relationship using double luciferase report. The expression detection of FN-1 protein in cells of each group found that the expression of miR-144-3p in cells of the over-expression group was significantly higher than that of the blank and the independence sequence groups, while the expression of FN-1 protein was significantly lower than that of the two groups. In contrast, the expression of miR-144-3p in cells of the inhibition group was significantly lower than that of the blank and the independence sequence groups, while the expression of FN-1 protein was significantly higher than that of the two groups. These results suggest that the over-expression of miR-144-3p reduces the expression of FN-1 protein in cells of trabecular meshwork oxidative stress models. Moreover, the detection showed that the proliferation and invasion of cells after modeling in the over-expression group were significantly enhanced compared with the other groups, which indicates that over-expression of miR-144-3p can upregulate the proliferation and migration of HTMCs.

This study proved the expression of miR-144-3p in oxidative stress HTMCs and its role in regulating FN-1. However, there were still some limitations. First, a double luciferase experiment was not carried out. Although it has been confirmed in other studies, it is not clear whether there is any difference caused by the two different research directions. Second, this study served as a basic experiment, and whether miR-144-3p can be used as a potential target for clinical treatment of glaucoma has not been verified. Therefore, relevant experiments are to be carried out in clinic to confirm the potential value of miR-144-3p in the treatment of glaucoma.

To sum up, the over-expression of miR-144-3p promotes the proliferation and invasion of HTMCs by inhibiting the expression of FN-1 in oxidative stress HTMCs, and is a potential target for glaucoma treatment.
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![Expression of serum miR-144-3p in the observation and normal groups. Expression of serum miR-144-3p in the two groups detected by RT-qPCR showed that the expression in the normal group was significantly higher than that in the observation group. \*\*\*P\<0.001, significant difference between the two groups. miR, microRNA.](etm-18-01-0647-g00){#f1-etm-0-0-7584}

![OD value of cells in each group after 48 h of transfection. Cell proliferation detected by CCK-8 assay showed that the OD value in the over-expression group was significantly higher than that in the other groups (P\<0.05), and in the inhibition group was significantly lower than that in the other groups (P\<0.05). There was no difference between the blank and the independence sequence groups (P\>0.05), while the OD value in these two groups was significantly higher than that in the inhibition group but lower than that in the control and the over-expression groups (P\<0.05). \*P\<0.05, difference compared with the control group; ^\#^P\<0.05, difference compared with the blank group; ^△^P\<0.05, difference compared with the independence sequence group; ^▽^P\<0.05, difference compared with the inhibition group. miR, microRNA; OD, optical density.](etm-18-01-0647-g01){#f2-etm-0-0-7584}

![Cell invasion in each group after transfection. Cell invasion detected by Transwell assay showed that the number of cell-penetration in the over-expression group was significantly higher than that in the other groups (P\<0.05), and that in the inhibition group was the least compared with the other four groups (P\<0.05). There was no significant difference in the number of cell-penetration between the blank and independence sequence groups (P\>0.05), and the number in these two groups significantly decreased compared with the control and over-expression groups, but significantly increased compared with the inhibition group (P\<0.05). \*P\<0.05, difference compared with the control group; ^\#^P\<0.05, difference compared with the blank group; ^△^P\<0.05, difference compared with the independence sequence group; ^▽^P\<0.05, difference compared with the inhibition group.](etm-18-01-0647-g02){#f3-etm-0-0-7584}

![Relative expression of FN-1 protein in each group after transfection. Relative expression of FN-1 protein in cells detected by WB showed that the expression in the over-expression group was significantly lower than that in the other four groups (P\<0.05). The expression in the blank and the independence sequence groups had no significant difference (P\>0.05), but was significantly higher than that in the control and over-expression groups and significantly lower than that in the inhibition group (P\<0.05). The expression of FN-1 protein in the inhibition group was significantly higher than that in the other four groups (P\<0.05). \*P\<0.05, difference compared with the control group; ^\#^P\<0.05, difference compared with the blank group; ^△^P\<0.05, difference compared with the independence sequence group; ^▽^P\<0.05, difference compared with the inhibition group. FN-1, fibronectin-1.](etm-18-01-0647-g03){#f4-etm-0-0-7584}

###### 

Primer sequence.

  Gene         Upstream primer             Downstream primer
  ------------ --------------------------- -------------------------
  miR-144-3p   5′-CCCTACAGTATAGATGATG-3′   5′-TGCAGGGTCCGAGGT-3′
  U6           5′-TAGGGTGCTCGCTTCGGC-3′    5′-CTGGTGTCGTGGAGTCG-3′

miR, microRNA.

###### 

Expression of miR-144-3p in cells of each group.

  Group                   miR-144-3p                                                                                                F         P-value
  ----------------------- --------------------------------------------------------------------------------------------------------- --------- ---------
  Control                 1.450±0.102                                                                                                         
  Blank                   1.032±0.042^[a](#tfn2-etm-0-0-7584){ref-type="table-fn"}^                                                           
  Independence sequence   1.055±0.010^[a](#tfn2-etm-0-0-7584){ref-type="table-fn"}^                                                 100.954   \<0.001
  Inhibition              0.350±0.067^[a](#tfn2-etm-0-0-7584){ref-type="table-fn"}--[c](#tfn4-etm-0-0-7584){ref-type="table-fn"}^             
  Over-expression         7.167±1.07^[a](#tfn2-etm-0-0-7584){ref-type="table-fn"}--[d](#tfn5-etm-0-0-7584){ref-type="table-fn"}^              

Difference compared with the control group (P\<0.05)

Difference compared with the blank group (P\<0.05)

Difference compared with the independence sequence group (P\<0.05)

Difference compared with the inhibition group (P\<0.05). miR, microRNA.

###### 

Cell proliferation in each group after 48 h.

  Group                   OD value                                                                                                  F        P-value
  ----------------------- --------------------------------------------------------------------------------------------------------- -------- ---------
  Control                 0.842±0.115                                                                                                        
  Blank                   0.622±0.084^[a](#tfn6-etm-0-0-7584){ref-type="table-fn"}^                                                          
  Independence sequence   0.634±0.092^[a](#tfn6-etm-0-0-7584){ref-type="table-fn"}^                                                 29.146   \<0.001
  Inhibition              0.325±0.055^[a](#tfn6-etm-0-0-7584){ref-type="table-fn"}--[c](#tfn8-etm-0-0-7584){ref-type="table-fn"}^            
  Over-expression         1.241±0.165^[a](#tfn6-etm-0-0-7584){ref-type="table-fn"}--[d](#tfn9-etm-0-0-7584){ref-type="table-fn"}^            

Difference compared with the control group (P\<0.05)

Difference compared with the blank group (P\<0.05)

Difference compared with the independence sequence group (P\<0.05)

Difference compared with the inhibition group (P\<0.05). OD, optical density.

###### 

Cell-penetration in each group.

  Group                   No. of cell-penetration                                                                                      F        P-value
  ----------------------- ------------------------------------------------------------------------------------------------------------ -------- ---------
  Control                 139.54±11.66                                                                                                          
  Blank                   115.88±9.45^[a](#tfn10-etm-0-0-7584){ref-type="table-fn"}^                                                            
  Independence sequence   109.75±8.77^[a](#tfn10-etm-0-0-7584){ref-type="table-fn"}^                                                   52.656   \<0.001
  Inhibition              57.95±9.44^[a](#tfn10-etm-0-0-7584){ref-type="table-fn"}--[c](#tfn12-etm-0-0-7584){ref-type="table-fn"}^              
  Over-expression         188.15±15.74^[a](#tfn10-etm-0-0-7584){ref-type="table-fn"}--[d](#tfn13-etm-0-0-7584){ref-type="table-fn"}^            

Difference compared with the control group (P\<0.05)

Difference compared with the blank group (P\<0.05)

Difference compared with the independence sequence group (P\<0.05)

Difference compared with the inhibition group (P\<0.05).

###### 

Comparison of FN-1 protein.

  Group                   Relative expression of FN-1 protein                                                                         F        P-value
  ----------------------- ----------------------------------------------------------------------------------------------------------- -------- ---------
  Control                 0.684±0.054                                                                                                          
  Blank                   0.925±0.112^[a](#tfn14-etm-0-0-7584){ref-type="table-fn"}^                                                           
  Independence sequence   0.930±0.160^[a](#tfn14-etm-0-0-7584){ref-type="table-fn"}^                                                  25.611   \<0.001
  Inhibition              1.354±0.147^[a](#tfn14-etm-0-0-7584){ref-type="table-fn"}--[c](#tfn16-etm-0-0-7584){ref-type="table-fn"}^            
  Over-expression         0.459±0.049^[a](#tfn14-etm-0-0-7584){ref-type="table-fn"}--[d](#tfn17-etm-0-0-7584){ref-type="table-fn"}^            

Difference compared with the control group (P\<0.05)

Difference compared with the blan k group (P\<0.05)

Difference compared with the independence sequence group (P\<0.05)

Difference compared with the inhibition group (P\<0.05). FN-1, fibronectin-1.
